5- (3, 4-dichloro-phenyl) -N- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as HDL cholesterol raising agents

Details for Australian Patent Application No. 2010294277 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Roever, Stephan; Wright, Matthew

Agent Spruson & Ferguson

Pub. Number AU-A-2010294277

PCT Pub. Number WO2011/029827

Priority 09170097.1 11.09.09 EP

Filing date 8 September 2010

Wipo publication date 17 March 2011

International Classifications

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/465 (2006.01) - Nicotine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/029827 Priority application(s): WO2011/029827

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010294283-Process for preparing Cinacalcet

2010294274-Module arrangement consisting of solar modules